human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary Read More

Classification Information

Class [005]
Human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary arterial hypertension, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, cerebrovascular diseases and digital ulcers; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the prevention and treatment of neurological diseases, namely Alzheimer's, Huntington's disease, multiple sclerosis, and cerebral palsy; human pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; Human pharmaceutical preparations for the prevention and treatment of hemolytic disease of the newborn; human pharmaceuticals preparations, namely anxiolytic medications, anti-virals, anti-inflammatories, anti-infectives, anti-allergic medications, and human pharmaceutical preparations for the relief of pain.

Classification kind code

Mark Details

Serial Number

2270108

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 27^th Nov 2024	Advertised
Submitted for opposition 27 on 04^th Nov 2024	Approval Notice Sent
Submitted for opposition 26 on 04^th Nov 2024	Approved
Submitted for opposition 22 on 25^th Oct 2024	Search Recorded
Submitted for opposition 287 on 03^rd Aug 2023	Pre-Assessment Letter Sent
Submitted for opposition 30 on 18^th Jul 2023	Filed
Submitted for opposition 1 on 18^th Jul 2023	Created
Submitted for opposition 31 on 18^th Jul 2023	Formalized